home / stock / fsddf / fsddf quote
Last: | $ |
---|---|
Change Percent: | -3.51% |
Open: | $0.050798 |
Close: | $0.0419 |
High: | $0.050798 |
Low: | $0.0351 |
Volume: | 472,326 |
Last Trade Date Time: | 10/15/2019 07:24:54 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$ | $0.050798 | $0.0419 | $0.050798 | $0.0351 | 472,326 | 10-15-2019 |
$ | $0.050798 | $0.0419 | $0.050798 | $0.0351 | 472,326 | 10-14-2019 |
$ | $0.048 | $0.043425 | $0.048 | $0.03185 | 1,824,246 | 10-11-2019 |
$ | $0.0549 | $0.044625 | $0.058 | $0.04138 | 888,287 | 10-10-2019 |
$ | $0.059 | $0.055 | $0.0607 | $0.05 | 131,556 | 10-09-2019 |
$ | $0.0608 | $0.057325 | $0.0608 | $0.05 | 273,526 | 10-08-2019 |
$ | $0.0514 | $0.06 | $0.06214 | $0.05 | 115,937 | 10-07-2019 |
$ | $0.06 | $0.0583 | $0.063 | $0.055 | 427,026 | 10-04-2019 |
$ | $0.06 | $0.06 | $0.062 | $0.055 | 516,256 | 10-03-2019 |
$ | $0.067 | $0.0602 | $0.067 | $0.052 | 282,880 | 10-02-2019 |
$ | $0.064 | $0.06 | $0.0684 | $0.05622 | 592,910 | 10-01-2019 |
$ | $0.065 | $0.069 | $0.075 | $0.0635 | 65,063 | 09-30-2019 |
$ | $0.075 | $0.07 | $0.077 | $0.06675 | 128,833 | 09-27-2019 |
$ | $0.0708 | $0.0748 | $0.075 | $0.069 | 35,747 | 09-26-2019 |
$ | $0.075 | $0.0736 | $0.075 | $0.068 | 145,450 | 09-25-2019 |
$ | $0.06925 | $0.077 | $0.0772 | $0.0635 | 69,701 | 09-24-2019 |
$ | $0.0735 | $0.0769 | $0.0769 | $0.07 | 64,881 | 09-23-2019 |
$ | $0.0753 | $0.07726 | $0.0782 | $0.0714 | 54,561 | 09-20-2019 |
$ | $0.079 | $0.073 | $0.079 | $0.073 | 189,603 | 09-19-2019 |
$ | $0.081 | $0.0779 | $0.081 | $0.073 | 26,452 | 09-18-2019 |
News, Short Squeeze, Breakout and More Instantly...
FSD Pharma Inc - Class B Company Name:
FSDDF Stock Symbol:
OTCMKTS Market:
FSD Pharma Announces Closing of C$10.125 Million Private Placement to Institutional Investors Canada NewsWire TORONTO, June 9, 2020 TORONTO , June 9, 2020 /CNW/ - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) (the "Company") announces the cl...
FSD Pharma Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis Canada NewsWire TORONTO, June 3, 2020 TORONTO , June 3, 2020 /CNW/ - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: ...
FSD Pharma Monetizes Non-Core Asset with Sale of Partial Equity Stake in Pharmadrug Inc. Canada NewsWire TORONTO, May 21, 2020 - Buyer Holds Option to Purchase Additional Shares - TORONTO , May 21, 2020 /CNW/ - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA...